Cargando…
FRI649 ADMIRE: Assessing Dapagliflozin And Metformin As An Initial Regimen In Diabetes Mellitus For Enhanced Glucose Control
Disclosure: D. Phadke: None. D. Gopal: None. D. Biswas: None. D. Birla: None. A. Prasad: None. P. Joshi: None. Introduction: Early aggressive glucose lowering in type 2 diabetes mellitus (T2DM) has shown improved outcomes, and combination oral antidiabetic agents (OAAs) on top of lifestyle therapy a...
Autores principales: | Phadke, Dr Uday, Gopal, Dr Jayashree, Biswas, Dr Kaushik, Birla, Dr Ashish, Prasad, Ashish, Joshi, Priyanka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555281/ http://dx.doi.org/10.1210/jendso/bvad114.868 |
Ejemplares similares
-
FRI651 Usage Of Modern Sulphonylureas And Metformin Fixed Dose Combination (fdc) In Type 2 Diabetes Mellitus (t2dm) Patients With Established Complications
por: M, Aushili, et al.
Publicado: (2023) -
PSUN228 Incidence and Predictors of New Onset Diabetes After Transplant (NODAT) in Liver Transplant recipients.
por: Sheth, Kaushal, et al.
Publicado: (2022) -
FRI636 Sleep Architecture In Diabetic Patients With Sleep Apnea On Metformin
por: Varma, Madhu, et al.
Publicado: (2023) -
LBODP054 Hypogonadism in Diabetes Mellitus: Insulin Resistance, The Connecting Link?
por: Singh, Jaspreet, et al.
Publicado: (2022) -
ODP649 COVID-19 Induced Diabetic Ketoacidosis Which Unmasked Latent Autoimmune Diabetes In Adult
por: Alqaisi, Sura, et al.
Publicado: (2022)